BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Intestine
,
Laser capture microdissection
,
Cisplatin
,
rs2300478
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mutant cells
Summary
General Info
Curated Studies
Most Correlated Studies
Imprints of circulating monocytes of patients with Familial Hypercholesterolemia
Lung cancer HCC827 EGFR-mutant cells following treatment with targeted therapies
BY4741 yeast PDR5 mutant cells treated with citrinin and or ochratoxin A
The Immunological Genome Project - Immune cell lineage differentiation and maturation
Expression profile of AML1-ETO induction and knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Molecular interplay between mutant p53 proteins and autophagy in cancer cells.
Cytomegalovirus UL128 homolog mutants that form a pentameric complex produce virus with impaired epi…
Restoration of the tumor-suppressor function to mutant p53 by Ganoderma lucidum polysaccharides in c…
A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes.
Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 ind…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
A Study of the Effects of PEITC on Oral Cells With Mutant p53
Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage ⅢA-N2 Non-small Cell Lung Cancer
Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cel…
Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell L…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ